HopeStage
Back to all studies
CompletedNCT00080158

Three treatment approaches for teens with depression after a suicide attempt

About this titleRead the official source — NCT00080158
Medication studyAges 12–18United States
The study in practice

Understand this study

Who was this study for?

Listed age limits: 12 years to 18 years.

Listed locations
Baltimore and 5 more locationsSee all locations and recruitment
Study phase
Phase 2 / Phase 3This study spans more than one phase, so it may combine goals such as safety, dosing, and early effectiveness.

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateMarch 2004
Recruitment status
Completed
Enrollment listed in the registry
120
Sponsor
New York State Psychiatric Institute
Sponsor type
Research institute
Study type
Drug
Intervention type
Behavioural, Drug
Study phase
Phase 2 / Phase 3This study spans more than one phase, so it may combine goals such as safety, dosing, and early effectiveness.
Locations
United States
Age range
From 12 Years to 18 Years
Official registry ID
NCT00080158
Official title
Show the full official title

Treatment of Adolescent Suicide Attempters (TASA)

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Baltimore · New York · Durham

2 more locations
  • Pittsburgh
  • Dallas

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is New York State Psychiatric Institute, a research institute.

Did this study involve medication?

Yes. The study involved medication, including fluoxetine, sertraline, citalopram, escitalopram, bupropion, mirtazapine, venlafaxine and lithium.

Who was this study for?

Listed age limits: 12 years to 18 years.

Want to explore more studies?

Explore studies